Asahi Kasei to acquire Veloxis Pharmaceuticals for $1.3bn

This article was originally published here

The Japanese conglomerate plans to acquire Veloxis Pharmaceuticals through its Danish subsidiary Asahi Kasei Pharma Denmark in a move to accelerate its transformation into a global healthcare company.

The post Asahi Kasei to acquire Veloxis Pharmaceuticals for $1.3bn appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply